Product NDC: | 33342-019 |
Proprietary Name: | Pantoprazole sodium |
Non Proprietary Name: | Pantoprazole sodium |
Active Ingredient(s): | 20 mg/1 & nbsp; Pantoprazole sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 33342-019 |
Labeler Name: | Macleods Pharmaceuticals Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200821 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111203 |
Package NDC: | 33342-019-10 |
Package Description: | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (33342-019-10) |
NDC Code | 33342-019-10 |
Proprietary Name | Pantoprazole sodium |
Package Description | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (33342-019-10) |
Product NDC | 33342-019 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pantoprazole sodium |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20111203 |
Marketing Category Name | ANDA |
Labeler Name | Macleods Pharmaceuticals Limited |
Substance Name | PANTOPRAZOLE SODIUM |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |